The device will be tested in high-risk percutaneous coronary intervention (PCI) patients.

Ambient air pollution directly leads to poorer health outcomes, and even short-term exposure to fine particulate matter can increase a person’s risk of adverse cardiovascular events.

The Montreal Heart Institute has been able to operate at a normal pace and keep COVID-19 at bay—and its specialists think other hospitals could learn a thing or two from their experience.

Fractional flow reserve guidance can help cardiologists make better decisions during percutaneous coronary intervention—can it lead to better outcomes for patients with stable angina pectoris?

A new study at the University of Cincinnati aims to find out why some TAVR patients experience clotting issues that can lead to substantial side effects.

Welldoc, a Columbia, Maryland-based digital health company, has gained an additional FDA approval for its BlueStar diabetes management solution.

The approach was on-par with CT scan quality at detecting some of the most common findings associated with the disease, including lesions and ground-glass opacities, experts wrote in the Journal of MRI.

The Florida physician firm had been in advanced discussions to exit imaging before the pandemic and plans to move forward with a sale "when market conditions are appropriate."